The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 20, 2016

Filed:

Mar. 07, 2011
Applicants:

Jin Sook Kim, I, Seoul, KR;

Jung Hyun Kim, Seoul, KR;

Young Sook Kim, Daejeon, KR;

Chan-sik Kim, Daejeon, KR;

Ohn Soon Kim, Daejeon, KR;

Eun Jin Shon, Daejeon, KR;

Nam-hee Yoo, Daejeon, KR;

Yun MI Lee, Daejeon, KR;

Dong Ho Jung, Daejeon, KR;

Inventors:

Jin Sook Kim, I, Seoul, KR;

Jung Hyun Kim, Seoul, KR;

Young Sook Kim, Daejeon, KR;

Chan-Sik Kim, Daejeon, KR;

Ohn Soon Kim, Daejeon, KR;

Eun Jin Shon, Daejeon, KR;

Nam-Hee Yoo, Daejeon, KR;

Yun Mi Lee, Daejeon, KR;

Dong Ho Jung, Daejeon, KR;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 36/47 (2006.01); A61K 36/00 (2006.01); A23L 1/30 (2006.01); A23L 1/314 (2006.01); A23L 1/39 (2006.01); A23L 2/52 (2006.01); A23K 1/16 (2006.01); A23K 1/18 (2006.01);
U.S. Cl.
CPC ...
A61K 36/00 (2013.01); A23K 1/1646 (2013.01); A23K 1/184 (2013.01); A23K 1/1813 (2013.01); A23K 1/1826 (2013.01); A23L 1/3002 (2013.01); A23L 1/31436 (2013.01); A23L 1/39 (2013.01); A23L 2/52 (2013.01); A61K 36/47 (2013.01); A23C 2240/15 (2013.01);
Abstract

The present invention relates to a pharmaceutical composition for the prevention and treatment of diabetic complications comprising the extract ofLour. or the fraction thereof as an active ingredient. More particularly, the extract ofLour. or the fractions thereof of the present invention can inhibit the activity of aldose reductase and the generation of the advanced glycation endproducts, the index of diabetic complications, and have powerful activity of inhibiting diabetic complications with brining the anti-cataract, anti-retinopathy, and anti-neuropathy effect, and have the activity of anti-oxidation as well, so that they can be effectively used as an active ingredient of a pharmaceutical composition for the prevention and treatment of diabetic complications.


Find Patent Forward Citations

Loading…